Indications for Use | Clinical Evidence | NOPAIN Act | Training & Ordering | Provider Portal | Contact
Morph and POSP utilize Percutaneous Nerve Field Stimulation (PNFS).
Three percutaneous leads are placed at targeted auricular sites and connected to an external stimulator. Low-level electrical impulses modulate afferent nerve branches influencing central pain, mood, and stress pathways. Stimulation is well-tolerated, with most patients reporting minimal or no ongoing sensation after initial placement.
Indications for Use
Clinical Evidence
Cesarean section (510(k) K221425)
Cardiac surgery (510(k) K221425)
Diabetic neuropathy (510(k) K212859)
Adolescent IBS (510(k) K202940)
Opioid withdrawal (510(k) K221231)
NOPAIN Act
Effective January 1, 2025 – December 31, 2027
Federal law mandating separate Medicare reimbursement for qualifying non-opioid pain management therapies used during outpatient surgeries (ASC and HOPD settings).
Why It Matters to Providers Now
New Reimbursement Opportunities
Regulatory and Risk Mitigation
Patient Demand and Market Differentiation
Improved Outcomes, Fewer Complications
Enhanced Clinical and Economic Performance
Ordering & Training
Once you’ve placed an initial order, our team will coordinate with you to schedule training. Our National Trainer delivers comprehensive 2-day training in theory, technology, sanitation, installation, patient monitoring, and follow up. Upon completion, they will be issued certificates of completion. They will also have access to our library of training resources for future reference - and our marketing library to immediately begin sharing this life-changing new in-office treatment option with your patients.
Coming Soon - Exclusive Partner Resources
Provider Portal
Access partner-only resources including educational and training materials, marketing collateral, billing support and easy ordering for you and your staff.